This online course has been produced by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. The main topics addressed in the educational programme are: 1. Management of angina pectoris and 2. Management of heart failure.
The content in this educational programme is based on the latest guideline recommendations of the European Society of Cardiology for the management of these two important and prevalent conditions.
The Angina Pectoris section comprises five modules addressing the following topics: 1-Characteristics of angina, definition, epidemiology, pathogenesis, microvascular angina; 2-Clinical presentation, diagnosis and patient risk stratification; 3-Management of risk factors – Prevention; 4-Pharmacological therapy and 5-Myocardial revascularisation and management of comorbidities.
The Heart Failure section comprises three modules, namely 1-Definition of heart failure, brief historical notes, epidemiology and pathogenesis; 2-Clinical presentation and diagnosis and 3-The basis for defining treatment strategies.
Modules are presented as Power Point slide presentations and people taking the course will be able to run these presentations at their own pace.
Multiple Choice Questions (MCQ) addressing the key areas of interest in each of the modules will be used to evaluate the learning process. Certificates of approval will be issued by the Working Group on Cardiovascular Pharmacotherapy to those students who achieved an overall mark 70% or above.
This online educational activity aims at providing insight into the recent advances in the management of angina and heart failure, two of the most common and clinically important cardiovascular conditions affecting people worldwide. The information provided in the course is based on the most recent guidelines of the European Society of Cardiology.
The main objective of this educational activity is to provide students with objective, evidence based, information on the clinical assessment of patients with angina and or heart failure, diagnostic pathways and effective treatment options in both angina and heart failure.
Another major educational objective is to make the attendees aware of the several pathogenetic mechanisms responsible for the different presentation of these two clinical conditions.
Who should take this Course
Cardiologists, Cardiology trainees, General Medicine physicians, General Medicine trainees, Nurses with a specific interest in ischaemic heart disease and/or heart failure and health care professionals with an interest in angina and heart failure.
Credits & Certificates
2 EBAC credits
Benefits of taking this Course
In addition to becoming acquainted with the clinical presentation of angina pectoris and heart failure, their pathogenetic mechanisms, diagnostic pathways and treatment strategies, those individuals registering for the online course will be invited to become members of the ESC Working Group of Cardiovascular Pharmacotherapy (no fee).
Those individuals completing the course will acquire 2 EBAC credits and students taken the MCQ at the end of the course and obtaining a mark equal or above 70% will receive a Certificate of Approval/Course completion from the ESC Working Group.
Sponsorship & Disclaimers
This online activity was supported by an unrestricted educational grant by Servier.
Click to entroll now